Literature DB >> 11966555

Gabapentin: pharmacology and its use in pain management.

M A Rose1, P C A Kam.   

Abstract

Although its exact mode of action is not known, gabapentin appears to have a unique effect on voltage-dependent calcium ion channels at the postsynaptic dorsal horns and may, therefore, interrupt the series of events that possibly leads to the experience of a neuropathic pain sensation. Gabapentin is especially effective at relieving allodynia and hyperalgesia in animal models. It has been shown to be efficacious in numerous small clinical studies and case reports in a wide variety of pain syndromes. Gabapentin has been clearly demonstrated to be effective for the treatment of neuropathic pain in diabetic neuropathy and postherpetic neuralgia. This evidence, combined with its favourable side-effect profile in various patient groups (including the elderly) and lack of drug interactions, makes it an attractive agent. Therefore, gabapentin should be considered an important drug in the management of neuropathic pain syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966555     DOI: 10.1046/j.0003-2409.2001.02399.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  94 in total

1.  Gabapentin-induced severe myoclonus in a patient with impaired renal function.

Authors:  Martin Holtkamp; Annett Halle; Hartmut Meierkord; Florian Masuhr
Journal:  J Neurol       Date:  2005-08-25       Impact factor: 4.849

Review 2.  Palliative radiation therapy for canine osteosarcoma.

Authors:  Monique N Mayer; Candace K Grier
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

3.  Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons.

Authors:  Jared Minkel; Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2013-09-01

4.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 5.  Challenging neurological symptoms in paediatric palliative care: An approach to symptom evaluation and management in children with neurological impairment.

Authors:  Lisa Ann Rasmussen; Marie-Claude Grégoire
Journal:  Paediatr Child Health       Date:  2015-04       Impact factor: 2.253

6.  Thrombospondin-4 and excitatory synaptogenesis promote spinal sensitization after painful mechanical joint injury.

Authors:  Nathan D Crosby; Frank Zaucke; Jeffrey V Kras; Ling Dong; Z David Luo; Beth A Winkelstein
Journal:  Exp Neurol       Date:  2014-12-05       Impact factor: 5.330

7.  Gabapentin alleviates facet-mediated pain in the rat through reduced neuronal hyperexcitability and astrocytic activation in the spinal cord.

Authors:  Ling Dong; Nathan D Crosby; Beth A Winkelstein
Journal:  J Pain       Date:  2013-10-04       Impact factor: 5.820

8.  Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model.

Authors:  Matthew M Smiley; Ying Lu; Louis P Vera-Portocarrero; Amr Zidan; Karin N Westlund
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

Review 9.  Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Authors:  Matthew Brensilver; Keith G Heinzerling; Steven Shoptaw
Journal:  Drug Alcohol Rev       Date:  2013-04-25

10.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.